Medtronic Plc Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Medtronic Plc on March 12, 2025. The report discloses a transition of the company's Principal Accounting Officer. Medtronic Plc is incorporated in Ireland and its ordinary shares and various senior notes are registered on the New York Stock Exchange.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the departure of Jennifer M. Kirk, Global Controller and Principal Accounting Officer, effective May 2, 2025. Ms. Kirk is resigning to become the CEO of Exubrion Therapeutics. The filing explicitly states her resignation did not result from any disagreement regarding the company's operations, policies, or practices.
Management Commentary and Personnel Transition
- Successor Appointment: Denise L. Blomquist, currently Assistant Global Controller, has been appointed as the new Global Controller and Principal Accounting Officer, effective March 17, 2025.
- Transition Plan: Ms. Kirk will remain with the company until May 2, 2025, to ensure a smooth transition.
- Successor Background: Ms. Blomquist has been employed by Medtronic since 2004, holding roles of increasing responsibility within the finance organization for 21 years. She previously worked as a finance director at Opus Northwest and holds a bachelor's degree in accounting from the University of Wisconsin - Madison.
- Compensation: Ms. Blomquist will receive a base salary and participate in the Medtronic Incentive Plan (MIP) and the 2021 Long-Term Incentive Plan (LTIP) at levels commensurate with similarly situated officers. Her employment is on an at-will basis.
Key Facts for Investor Verification
- Verify the effective dates of the resignation (May 2, 2025) and the new appointment (March 17, 2025).
- Confirm that the resignation of the Principal Accounting Officer was not due to any disagreement with the company.
- Note that the new Principal Accounting Officer, Denise L. Blomquist, is an internal promotion with 21 years of tenure at the company.
- Review the definitive proxy statement filed on August 9, 2024, for details on the MIP, LTIP, and Change in Control Policy applicable to the new appointee.